Clinical trial
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
NCT02500784
Study timeline
Study start (estimated)2023-01-01Date precision: month
Registry last updated2020-09-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Cognitive Dysfunctionunresolved
Interventions
Formoterol ADRUG
Sponsors & collaborators
Palo Alto Veterans Institute for Researchlead sponsor
Alzheimer's Associationcollaborator
Mylan Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02500784 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.